Comparison of Different Methods of CAPTure of Circulating Tumour Cells (CTC) in Patients With Metastatic Breast or Prostate Cancer
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This trial is a pilot, prospective, single-center study conducted in a population of patients with metastatic breast cancer (whatever the immunohistochemical subtype) or metastatic prostate cancer. The aim of this exploratory study is to compare the sensitivity of three different techniques (CellSearch®, Parsortix® and SmartCatch®) in detecting circulating tumor cells (CTCs). After the patient's agreement, and before starting anti-tumor treatment, a blood sample will be taken using the 3 different CTC detection techniques. Each patient will participate in the study for one day. A total of 54 evaluable patients (36 patients with metastatic breast cancer and 18 patients with metastatic prostate cancer) will be included in this interventional study.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Diagnoza raka piersi (niezależnie od typu) lub raka prostaty z przerzutami, kwalifikujący się do nowego leczenia
- •Pacjent nie rozpoczął jeszcze nowego leczenia raka piersi lub prostaty
- •Wiek co najmniej 18 lat i dobry stan ogólny (WHO ≤ 2)
- •Ubezpieczenie w systemie ubezpieczeń społecznych we Francji
- •Podpisana świadoma zgoda na uczestnictwo w badaniu
✗ Disqualifies
- •Inne choroby, które mogą utrudnić przebieg badania
- •Problemy psychiczne, rodzinne, geograficzne lub społeczne uniemożliwiające regularne wizyty i wykonywanie procedur badania
- •Pacjent pozbawiony wolności lub pod opieką prawną
- •Nowotwór w historii pacjenta w ciągu ostatnich 5 lat (poza rakiem in situ piersi lub szyjki macicy)
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- May 27, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
IUCT-O
Toulouse, France
Trial contact
Florence DALENC
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/1/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.